Daiichi Seeks High Court Review Of Panel’s Reversal In Patent Drug Dispute

(September 16, 2015, 4:10 PM EDT) -- WASHINGTON, D.C. — The U.S. Supreme Court should review a drug patent infringement lawsuit over Apotex Inc.’s efforts to end Mylan Pharmaceuticals Inc.’s generic exclusivity for “Benicar” hypertension drug through a...
To view the full article, register now.